non glp 1 drugs for weight loss Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 medications for weight loss

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) Diabet Med

Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases

Ann Clin Lab Sci 2015;45:287291

Exenatide, dapagliflozin, or Phentermine/Topiramate differentially affect metabolic profiles in polycystic ovary syndrome

So, 47% more people lose more than 10% of body weight on lifestyle interventions with semaglutide compared to lifestyle interventions alone